Cleared Special

K161803 - Traxcess .007 Mini Guidewire

K161803 is an FDA 510(k) clearance for Traxcess .007 Mini Guidewire, manufactured by MicroVention, Inc.. The device is a Class 2 Neurology device with product code MOF cleared through the Special 510(k) pathway after a 92-day FDA review.

K161803 · MicroVention, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2016
Decision
92d
Days
Class 2
Risk

K161803 is an FDA 510(k) clearance for the Traxcess .007 Mini Guidewire. Classified as Guide, Wire, Catheter, Neurovasculature (product code MOF), Class II - Special Controls.

Submitted by MicroVention, Inc. (Tistin, US). The FDA issued a Cleared decision on September 30, 2016 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1330 - the FDA neurology device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all MicroVention, Inc. devices

FDA 510(k) Submission Details - K161803

510(k) Number K161803 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 30, 2016
Decision Date September 30, 2016
Days to Decision 92 days
Submission Type Special
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 148d · This submission: 92d
Pathway characteristics
Modification to existing cleared device.

MOF Device Classification - Class 2, Special Controls

Product Code MOF Guide, Wire, Catheter, Neurovasculature
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - MOF Guide, Wire, Catheter, Neurovasculature

All 38
Devices cleared under the same product code (MOF) and FDA review panel - the closest regulatory comparables to K161803.
ASAHI Neurovasulature Guide Wire: ASAHI CHIKAI black 18 soft tip
K171613 · Asahi Intecc Co., Ltd. · Jul 2017
Traxcess 7 Mini XSoft Guidewire
K163154 · MicroVention, Inc. · Dec 2016
ASAHI Neurovascular Guide Wire: ASAHI CHIKAI black 14 soft tip
K161912 · Asahi Intecc Co., Ltd. · Oct 2016
ASAHI CHIKAI Neurovascular Guide Wire (Round Curve)
K160659 · Asahi Intecc Co., Ltd. · Apr 2016
Traxcess Pro 14 Guidewire
K153053 · MicroVention, Inc. · Dec 2015
ASAHI NEUROVASCULAR GUIDE WIRE ASAHI CHIKAI 008, ASAHI NEUROVASCULAR GUIDE WIRE ASAHI CHIKAI BLACK, ASAHI NEUROVASCULAR
K141751 · Asahi Intecc Co., Ltd. · Jan 2015